Chief Executive Officer

Raymond Pizinger MBA

Mr. Pizinger brings over 30 years of medical device industry experience from start-ups to multi-billion dollar giants like Johnson & Johnson, including executive management and compliance. He has worked to take companies through an IPO on the NASDAQ, done due diligent assessments on acquisitions, and understands the importance of positioning a company for growth.

President/Medical Director
Yakov Katsnelson MD, PhD

Dr. Katsnelson brings more than 25 years as a lead researcher in the Transcranial Electrical Stimulation (TES) field. He has 5 patents related to TES and more than 100 publications on TES. He stands alone as the world’s leading scientist in TES research and development.

Vice President/New Product Development & Intellectual Property

Michael Jackson

Mr. Jackson brings a lifetime of scientific experience in working with waveform theory and applications where he has several patents to his name. He assisted Dr. Katsnelson in the design of the TESA (Nexalin TES Device) and led the development of Nexalin devices from hand-wired prototypes to production-manufactured models. He has secured and is also exploring several patent options for the Nexalin technology.

Director of Clinical Affairs

Dawn Rice, RN, MBA, CCRA

Ms. Rice brings 20 years of clinical operations and regulatory experience within the medical device industry. She has managed multiple phase clinical investigations from initial feasibility trials to post approval surveillance trials. She has lead programs from the initial start-up phase through product commercialization.

Technical Director

Eric B. Linder, MBA

Mr. Linder brings over a decade of medical device research, development, and production to the Kalaco team. Graduating summa cum laude with Biomedical Engineering and Master of Business degrees from Arizona State University, Mr. Linder has demonstrated expertise in the areas of project management, product development, and supply chain management. He has re-engineered the technical departments of several small companies to maximize production while minimizing costs.